TSC commences 2000 metres of drilling at Rover

Published 13-NOV-2019 14:31 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Having now secured approval, TSC Limited (ASX:TSC) has started a circa 2,000 metre reverse circulation (RC) drilling campaign at the Rover Project in the Western Australian goldfields.

TSC’s ability to quickly transition to drilling within nine months of commencing exploration activities is a credit to management, and investors appear to be closely following the group’s much anticipated campaign given the share price spike of 25% on Wednesday morning.

While the upcoming campaign could well deliver strong results, there are many more priority targets along strike towards Creasy 3 that will form the basis of future drilling programs.

In the short term though, the priority areas for drilling are along the 20 kilometre gold strike which is part of the Maynard Hills greenstone belt, on the eastern boundary.

This will involve the drilling of historic economic gold intercepts at Creasy 1, as well as examining new gold/VMS targets around Creasy 2 which are further south-west along the 20 kilometre known gold strike.

These targets have been identified through the analysis of aeromagnetic data.

The proposed drilling area can be seen on the following map which also shows prominent projects in relatively close proximity to the Rover strike.

The proposed drilling area is close to prominent projects.
The proposed drilling area is close to prominent projects.

Shallow economic gold intercepts already delineated

The Creasy 1 target comprises gold mineralisation located along the Illara shear zone where it dips steeply west, parallel to the sheared contact between the rock sequences.

Shallow historic RC and RAB drilling outlined anomalous gold mineralisation over a strike extent of about 1.2 kilometres which is open down dip and along strike to the north and south.

There are historic shallow economic intercepts in RC drill-holes up to 3 metres at 1.9 g/t gold from 53 metres.

Geological work conducted by TSC has materially extended gold anomalism in soils south-west of Creasy 1.

More importantly, rock-chips up to 1.2 g/t gold (RVR074) were found in banded iron formation (BIF) 800 metres south and 1.7 g/t gold (RVR013) 500 metres to the north of the nearest drill-holes as shown below.

TSC’s initial drilling plans are to confirm the presence of gold mineralisation at Creasy 1, then progressively test the potential down dip and along strike.

The priority is to search for areas of that show continuity of high grade mineralisation.

One of the key priorities at Creasy 2 will be to follow-up on promising assay results that confirmed a 200 metre long zinc-lead anomaly in soils and rock-chips within a broader copper and gold soil anomaly.

As coincident zinc-copper-gold mineralisation is typically common in VMS systems, drilling will test for mineralisation underneath this system.

Management expects to have the drilling program completed within three weeks, providing shareholders with an early insight into what may lie ahead as assay results come to hand.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X